SPDR S&P Pharmaceuticals ... (XPH)
AMEX: XPH
· Real-Time Price · USD
47.60
0.00 (0.00%)
At close: Sep 09, 2025, 3:20 PM
0.00% (1D)
| Bid | 47.59 |
| Market Cap | 261.84M |
| AUM | 186.96M |
| NAV | 47.33 |
| EPS (ttm) | 3.27 |
| PE Ratio (ttm) | 14.54 |
| Shares Out | 5.5M |
| Inception Date | Jun 19, 2006 |
| Ask | 47.7 |
| Volume | 10.32K |
| Open | 47.72 |
| Previous Close | 47.60 |
| Day's Range | 47.31 - 47.72 |
| 52-Week Range | 35.22 - 48.76 |
| Holdings | 42 |
| Expense Ratio | 0.35% |
About XPH
The SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the “Index”)Seeks to provide exposure to the pharmaceuticals segment of the S&P TMI, which comprises the Pharmaceuticals sub-industrySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing
Asset Class Equity
Ticker Symbol XPH
Inception Date Jun 19, 2006
Provider State Street
Website Fund Home Page
Exchange AMEX
Top 10 Holdings 37.55% of assets
| Name | Symbol | Weight |
|---|---|---|
| Tarsus Pharmaceutica... | TARS | 4.57% |
| Elanco Animal Health... | ELAN | 4.22% |
| Jazz Pharmaceuticals... | JAZZ | 3.83% |
| Viatris Inc. | VTRS | 3.82% |
| Axsome Therapeutics,... | AXSM | 3.78% |
| Johnson & Johnson | JNJ | 3.75% |
| Royalty Pharma Plc | RPRX | 3.46% |
| Merck & Co., Inc. | MRK | 3.44% |
| Organon & Co. | OGN | 3.36% |
| Pfizer Inc. | PFE | 3.32% |
Dividends Dividend Yield 1.46%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Jun 23, 2025 | $0.0959 | Jun 25, 2025 |
| Mar 24, 2025 | $0.1533 | Mar 26, 2025 |
| Dec 23, 2024 | $0.1548 | Dec 26, 2024 |
| Sep 23, 2024 | $0.1947 | Sep 25, 2024 |
| Jun 24, 2024 | $0.1557 | Jun 26, 2024 |
